Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-08-004970
Filing Date
2008-06-20
Accepted
2008-06-20 16:07:43
Documents
8

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. g06286b3sv1za.htm S-1/A 1958821
2 EX-10.25 MANUFACTURING AGREEMENT g06286b3exv10w25.htm EX-10.25 114988
3 EX-23.1 CONSENT OF KPMG LLP. g06286b3exv23w1.htm EX-23.1 2678
4 EX-23.3 CONSENT OF MORGAN JOSEPH & CO. INC. g06286b3exv23w3.htm EX-23.3 3036
7 GRAPHIC g06286b3g0628602.gif GRAPHIC 3768
8 GRAPHIC g06286b3g0628610.gif GRAPHIC 337
9 GRAPHIC g06286b3g0628630.gif GRAPHIC 14777
10 filename10.htm CORRESP 12038
  Complete submission text file 0000950144-08-004970.txt   2119451
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 08910205
SIC: 2834 Pharmaceutical Preparations